Sign in
TerminatedNo phase

Adult MDW Dual Cut-Off Accuracy Study

Key facts

Who runs it
Beckman Coulter, Inc.
Where
Detroit, Hackensack, Indianapolis, and Kansas City, United StatesSee the 5 sites
Trial code
Status
Terminated
People taking part
524 people enrolled
Started
12 Jun 2025
Ended
8 Jul 2026
Type of study
Observational
Treatments tested
  • Complete Blood Count with differential
Record updated
31 August 2026
Why it stopped
The study was discontinued due to a change in the company's strategic priorities for its hematology platform and was not related to concerns regarding the clinical performance, validity, or safety of MDW.

Who can take part

Age
18 years to 89 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Adults (18 to 89 years) of all races and ethnicities presenting to the ED
  • Whole Blood venous samples collected in K2EDTA while the patient was in the ED
  • First CBC w/diff test ordered within 12 hours of presentation to ED as part of their standard medical care
  • CBC w/diff tested within 2 hours of specimen collection
  • Subjects with at least ≥12 hours of follow-up in the ED (or inpatient, if admitted) from presentation

Who cannot take part

  • Subjects previously enrolled in this study (i.e. subjects may not be enrolled more than once in this study)
  • Subjects' data collected with Instrument Quality Control failure(s)
  • CBC w/diff test ordered after 12 hours of presentation to ED
  • Subjects discharged from ED <12 hours from ED presentation
  • ED Transfer Patients; Data Exclusions Post Enrollment:
  • Samples that have a system generated flag from the Standard of Care (SOC) CBC w/diff testing will be excluded
  • Samples with instrument flags, including vote outs and review flags for MDW will also be excluded (i.e. invalid MDW results)

Where in United States

  • Henry Ford Health SystemDetroit, United States
  • Hackensack University Medical CenterHackensack, United States
  • Indiana UniversityIndianapolis, United States
  • Kansas University Medical CenterKansas City, United States
  • Truman Medical CenterKansas City, United States

About the trial

What the trial wants to find out

This study will establish the clinical performance of the Monocyte Distribution Width (MDW) parameter on the DxH 900/ DxH 690T hematology analyzers to aid in the detection and risk assessment of patients in the Emergency Department (ED) for progression to sepsis.

The group in the trial

  • Adults presenting to Emergency Department

    All-comers study of adults (18 to 89 years) of all races and ethnicities presenting to the Emergency Department

    Treatment: Complete Blood Count with differential

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
UniCel DxH 900/690T Monocyte Distribution Width (MDW) Dual Cut-Off Clinical Accuracy Protocol
Record updated
31 August 2026